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a b s t r a c t
The intra-host evolutionary process of hepatitis C virus (HCV) was analyzed by phylogenetic and
coalescent methodologies in a patient co-infected with HCV-1a, HCV-2a, HCV-3a and human immuno-
deﬁciency virus (HIV) along a 13-year period.
Direct sequence analysis of the E2 and NS5A regions showed diverse evolutionary dynamics, in
agreement with different relationships between these regions and the host factors.
The Bayesian Skyline Plot analyses of the E2 sequences (cloned) yielded different intra-host
evolutionary patterns for each genotype: a steady state of a “consensus” sequence for HCV-1a; a pattern
of lineage splitting and extinction for HCV-2a; and a two-phase (drift/diversiﬁcation) process for HCV-3a.
Each genotype evolving in the same patient and at the same time presents a different pattern
apparently modulated by the immune pressure of the host.
This study provides useful information for the management of co-infected patients and provides
insights into the mechanisms behind the intra-host evolution of HCV.
& 2013 Elsevier Inc. All rights reserved.
Introduction
In 80% of the cases, Hepatitis C Virus (HCV) causes chronic
infections, which may, in turn, lead to the development of severe
hepatic complications, including cirrhosis and hepato-cellular
carcinoma (Lauer and Walker, 2001). It has been estimated that
about 2% of the world population may be chronically infected with
this virus (Lavanchi, 2009). Understanding the mechanisms by
which HCV causes chronic infections and regulates illness pro-
gression may improve the development of new vaccines and
therapeutic techniques.
HCV, together with other RNA-genome viruses, is a rapid evolving
pathogen (Kühnert et al., 2011). The crucial features of the infection
(e.g. immune evasion, therapy resistance and pathogenesis) may be
linked to the genetic diversity and in turn evolutionary processes that
have shaped the virus (Kuntzen et al., 2007; von Hahn et al., 2007).
Several studies have attempted to correlate different diversity indexes
with the host immune response (Bull et al., 2011), disease progression
(Farci et al., 2006) and response to treatment (Saludes et al., 2013).
Currently, the use of coalescence-based methods has improved the
possibility to recognize the intra-host diversiﬁcation process of HCV by
analyzing the dynamics of viral lineages in the host over the time
(Gray et al., 2012).
Most HCV intra-host evolutionary studies have been carried out
in different cases of chronic infection but evolutionary studies of
several viral strains in the same host are less common. However,
these researches require the analysis of co-infected patients in a
long follow-up period. These conditions can be fulﬁlled by study-
ing elderly patients with hemophilia (Qin et al., 2005) who
became infected by the use of non-inactivated human-derived
clotting factors. Unfortunately, these patients are often infected
with other blood-borne pathogens like the HIV (Lee, 2009).
In this study, we describe the evolution of two different regions of
the viral genomes of three HCV genotypes in a single HIV-co-infected
patient. Since the three genotypes evolved in a same host, the
evolution of each genotype may represent the different mechanisms
used by HCV to sustain the chronic infection. The study of multiple
variants in a single host may provide useful information for the
management of co-infected patients and provide insights into the
mechanisms behind the intra-host evolution of HCV.
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Results
The patient was co-infected with HCV-1a, 2a and 3a
To describe the genotype composition of each sample, 5 UTR-
RFLP and NS5B sequencing analyses were performed. The patient
was monitored throughout a period of 13 years. Samples were
analyzed at the start of the follow-up in 1993 (time code 4188) and
at 1995 (5168), 1997 (5679), 1998 (5974 and 6301), 1999 (6524),
2000 (6772), 2001 (7356), 2002 (7490), 2004 (8429) and 2006
(9107). All samples except sample 8429 (end of treatment)
produced the expected 250-bp amplicon from the 5′UTR which
allowed the detection of genotypes 1, 2 and 3, alone or in
combinations (Table 1). Further subtyping was carried out with
the NCBI's Viral Genotyping Tool using NS5B sequences (http://
www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi). The
NS5B sequences obtained from samples 5679 and 5974 were
classiﬁed as subtype 1a, that from sample 9107 as genotype 2a,
and that from sample 4188 as genotype 3a. Sample 8429 did not
produce any ampliﬁcation for NS5B. The remaining sequences
were not analyzed because their chromatograms showed several
mixed positions as may be expected in the presence of multiple
genotypes (Table 1). To resolve the mixed viral populations,
genotype speciﬁc primers were designed covering two regions
that showed different evolutionary patterns: the variable (ﬁrst half
of) E2 region and the relatively more conserved (second half of)
NS5A one (Supplementary Table 1). The results showed that in
most of the samples the patient was co-infected with at least two
genotypes (Table 1).
Phylogenetic analysis of direct sequences
To perform a genetic characterization of the different viral
strains, phylogenetic analyses were carried out. The sequences
obtained with genotype speciﬁc primers showed no evidence of
inter-genotype recombination (as assessed by the sliding window
methodology implemented in the NCBI's Viral genotyping tool).
The phylogenetic analysis using both the E2 and NS5A regions
grouped all samples sequenced, according to its primer design, in
genotypes 1a, 2a or 3a. Within each genotype, the patient's
samples formed clusters with strong statistical support. In addi-
tion, the tree topologies suggested a relationship between ances-
try and time of sampling (Fig. 1). The clustering and statistical
support of the patient's samples was maintained when the
analysis was carried out with more related sequences in the
GenBank (Supplementary Fig. 2).
The phylogeny of the samples was compatible with its time
To describe in detail the phylogenetic relationship between the
sequences of each genotype in both regions (E2 and NS5A), the
datasets of direct sequences were analyzed separately, since the
experimental design does not allow ruling out inter-genotype
recombination between these genomic regions. The model of the
nucleotide substitution used for all datasets was HKY (Hasegawa
et al., 1985), except for the E2 region of genotype 3a, which was
TrN (Tamura and Nei, 1993) with equal base frequencies. For the E2
region of HCV-2a, the rate heterogeneity among sites was modeled
as a proportion of invariant sites. As a result of exhaustive tree
searches, all datasets showed comb-like trees where the ancestry–
descendant relationship was compatible with the sampling time
(each sequence was close to the ancestor of the next one), except
for the E2 dataset of HCV-1a (Fig. 2).
The branch lengths and the time were correlated
To analyze the pattern observed in the previous analysis
quantitatively (i.e. if the sequences carried temporal information),
a linear regression analysis was performed. The correlation coefﬁ-
cients for the regressions (r2) and the slope (a rough estimation of
the substitution rate) for the E2 region were 0.0446 (substitution
rate not signiﬁcantly different from 0) for HCV-1a, 0.8516 (sub-
stitution rate of 9.90103 s/s/y) for HCV-2a, and 0.8478 (sub-
stitution rate of 3.53103 s/s/y) for HCV-3a (Table 2). In the
NS5A regions, the r2 values were 0.9356 for HCV-2a (substitution
rate of 1.17103 s/s/y) and 0.8497 for HCV-3a (estimated sub-
stitution rate of 1.14103 s/s/y) (Table 2). All datasets, except E2
HCV-1a, resulted in high correlation coefﬁcients and slopes sig-
niﬁcantly different from 0 (po0.05), indicating temporal structure
in these datasets (Fig. 2).
To conﬁrm the slopes obtained by linear regression, a Bayesian
coalesence analysis was carried out, yielding almost identical
estimations for the substitution rates (data not shown).
Intra-host viral population analysis
To analyze the diversiﬁcation process, a genetic population
study of molecular clones was performed using Coalescence
analyses in a Bayesian framework.
The intra-host HCV evolution was analyzed using clones from the E2
region
A total of 307 clones, including at least 14 clones per sample
and genotype, were sequenced (Supplementary Table 2).
Since nested PCR conditions are prone to artifactual recombina-
tion phenomena, the alignments of cloned sequences were analyzed
Table 1
Summary of the results for the different analyses carried out in each sample. Sample Code: Four-digit time code of the sample (measured as days from an arbitrary date in
the past). UTR (RFLP): Genotyping by RFLP analysis of the PCR product for the 5’UTR region. 1, 2 or 3 are the assigned genotype; 1/2: RFLP compatible with a mix of genotypes
1 and 2; NG: complex RFLP that did not allow the assignment of genotype. NS5B: result of the sequence analysis of the NS5B region. 1a, 2a or 3a: are the assigned subtype;
Mix: The electropherogram showed many nucleotide positions with multiple base possibilities. E2 and NS5A: Result of the genotype-speciﬁc PCR reaction for the E2 and
NS5A regions (the genotype speciﬁcity is indicated between parentheses). Seq: The PCR product was sequenced; þ; the PCR product was not enough to be sequenced; -: the
PCR produced no amplicons.
Region 4188 5168 5679 5974 6301 6524 6772 7356 7490 8429 9107
UTR (RFLP) 3 NG 1 1/2 1/2 1/2 2 2 2  2
NS5B 3a Mix 1a 1a Mix Mix Mix Mix Mix  2a
E2 (1a)  Seq Seq Seq Seq þ    
NS5A (1a)   Seq Seq þ     
E2 (2a)    þ Seq Seq Seq Seq Seq Seq
NS5A (2a) Seq þ Seq Seq Seq Seq Seq Seq Seq Seq
E2 (3a) Seq Seq – Seq Seq Seq Seq Seq Seq 
NS5A (3a) Seq Seq Seq Seq Seq Seq Seq Seq Seq 
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with Bellerophon (Huber et al., 2004) and also phylogenetically and
visually inspected to exclude recombinant sequences (chimeras)
between already sequenced “parental” clones. Four clones (5, 10, 21
and 22) of HCV-1a from sample 5168 were removed because they
showed evidence of recombination.
The phylogenetic analyses of the E2 sequences of HCV-2a and
3a cloned showed one highly supported monophyletic clade each,
whereas the HCV-1a cloned sequences showed two highly sup-
ported clades (bootstrap value of 100%), each related to a different
set of 1a sequences from GenBank (Supplementary Fig. 2G).
The diversity analysis using the mean Hamming distance
between the cloned sequences of the same time for each genotype
ranged between 0.54% and 1.83% (o2% expected as within host
diversity). Strikingly, the HCV-1a dataset showed a mean Ham-
ming distance of 7.15% for sample 5168 (42% but o15% as
expected for different lineages of the same subtype), which
supports the occurrence of two different lineages at the beginning
of the follow-up.
The mean Hamming distance provides rough information
about the true diversity of the viral population (Gray et al.,
2012). To overcome this issue, Bayesian Skyline Plot Analyses were
used to assess the changes in the sequence diversity through the
time (population dynamics). These plots showed that each
genotype exhibited particular proﬁles of population dynamics that
were not described by a simple (parametric) model. The Bayes
Factor analysis of the different demographic models also con-
ﬁrmed that the best ﬁt population model was, for the three
genotypes, the Bayesian Skyline Plot.
Supplementary Fig. 3 represents the evolutionary follow-up of
HCV-1a (I), 2a (II) and 3a (III), presented by the time-annotated
tree of the clones (a), the Bayesian Skyline Plot (b) and the mean
Hamming distance between the nucleotide sequences of the
clones (c) plotted over the same time scale (as suggested by
Gray et al. (2012)).
Genotype 1a: sequence stasis
The time-annotated tree for HCV-1a clones from variant
2 showed four clones in the ﬁrst sample (5168) (Fig. 3). In the
next time point (5679, after 511 days of evolution), the clones were
classiﬁed into two sub-lineages. Interestingly, the sequences of the
clones of the next time point (5974 after further 295 days of
evolution) were all related to one of the sub-lineages of the
previous sample, but in the last sample (6301 after another 326
days of evolution) the clones were related again to both sub-
lineages in 5679. At amino acid sequence level, the HCV-1a clones
Fig. 1. Maximum Likelihood Tree for the E2 (A) and NS5A (B) regions obtained with PhyML 3.0 using GTRþΓþ I as a model of nucleotide substitution as recommended by
ModelTest 3.07 (Akaike Information Criterion) for both datasets. The sequences with name in bold were obtained from samples of the patient studied and were named after
the sample code and the genotype for which the primers were designed. The rest of the sequences were named after their GenBank accession number and genotype. The
numbers above or below the branches represent the bootstrap support value (% over 1000 pseudoreplica).
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of all time points showed a high degree of similarity and only a
few mutations were detected sporadically. Noteworthy, no amino
acid mutations were ﬁxed at any position of the E2 region
including hyper-variable region 1 (HVR-1) along 3 years and 38
days of evolution. This apparently slow evolutionary process
resulted in the estimation of a nucleotide substitution rate of
Fig. 2. Molecular Clock Analyses of Direct Sequences. Each frame contains the information of each dataset of direct sequences. The following data are indicated from the top
to the bottom: Frame code, HCV genotype and HCV region; Maximum Likelihood Phylogenetic Tree obtained by exhaustive topology search; Branch length vs. Time
regression; Model of nucleotide substitution used for the phylogenetic analysis. HKY: Haseagua, Kishino and Yano (1985) model; þ I: model with a proportion of invariable
sites; TrN: Tamura and Nei (1993) model.
Table 2
Summary of the results for the substitution rate estimation. Genotype: Dataset sequence genotype. Region: Dataset sequence genomic region. Dataset type: type of
sequences. Direct: sequences from PCR product. Cloned: sequences from clones obtained from the PCR product. Method: method used. Regression: the rates were estimated
from the slope of the linear regression of the branch length against the time; in Remarks, it is stated if the null hypothesis of a slope equal to zero was rejected. BSP: the rates
were jointly estimated with the genealogy and the demographic history of the sequences in a Bayesian framework by the use of the Bayesian Skyline Plot; the model of
molecular clock that ﬁts with the data is stated in Remarks: Strict Clock or Uncorrelated Log-Normal (ULN) Relaxed Clock. Rate: nucleotide substitution rate. Lower and
Upper C.I.: Value of the lower and upper limits of the conﬁdence intervals for regression or the values of the upper and lower high posterior probability densities (95%) for
the Bayesian Skyline Plot analysis. n: the substitution rate of the NS5A region for HCV-1a was estimated as the Hamming distance (p-dist) between the two direct sequences
divided by the time span between them (time). n/a: not available.
Genotype Region Dataset type Method Rate (s/s/y) Lower C.I. (s/s/y) Upper C.I. (s/s/y) Remarks
1a E2 Direct Regression 8.99104 5.20102 5.38102 Slope¼0
1a E2 Cloned Regression 2.37103 1.29103 3.45103 Slopea0
1a E2 Cloned BSP 3.59103 2.34103 4.91103 ULN Relaxed Clock
1a NS5A Direct p-dist/time 7.30104 n/a n/a Only 2 sequences*
2a E2 Direct Regression 9.90103 2.31103 1.76102 Slopea0
2a E2 Cloned Regression 1.24102 1.16102 1.31102 Slopea0
2a E2 Cloned BSP 1.40102 1.03102 1.80102 Strict Clock
2a NS5A Direct Regression 1.17103 8.60104 1.48103 Slopea0
3a E2 Direct Regression 3.53103 1.81103 5.26102 Slopea0
3a E2 Cloned Regression 4.69103 4.38103 5.00103 Slopea0
3a E2 Cloned BSP 7.26103 5.45103 9.13103 ULN Relaxed Clock
3a NS5A Direct Regression 1.14103 6.60104 1.62103 Slopea0
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3.59103 s/s/y (between 2.34 and 4.91103 s/s/y) for the E2
region of HCV-1a (Table 2).
The Bayesian Skyline Plot obtained for HCV-1a showed a period of
constant population diversity until a time situated between samples
5168 and 5679. Diversity then increased about 10 times up to sample
5679, decreased until 5974, and ﬁnally remained constant until the
last HCV-1a sample. The mean Hamming distance (nucleotides) of the
clones ranged between 0.57% and 0.93% and showed no correlation
with the skyline proﬁle (Supplementary Fig. 3A).
Genotype 2a: lineage exchange
The time-annotated tree for HCV-2a clones showed the existence
of two groups of sequences in each time-point except for the last
sample (9107) (Fig. 4). The complexity of the evolutionary process
carried out by HCV-2a in this patient could be roughly described as
follows: The sequences cloned from the ﬁrst sample (6301) formed
two deﬁned groups: α and β, which remained with few changes 223
days later in the next sample (6524) as groups γ and δ respectively.
Interestingly, all the sequences cloned from the further samples were
related only to group δ, indicating the “extinction” (or at least the lack
of detection) of the lineage leading to group γ. A similar behavior was
observed throughout all the evolutionary process, suggesting a sub-
population shift characterized by the expansion of divergent
sequences that formed new lineages and led to the extinction of
others. This process is clearly observed at amino acid level, where, at
each time, two lineages with many amino acid differences at HVR-1
co-existed in the same sample. As a result of this quick turnover of
viral variants, the estimation of the substitution rate behind this
process was relatively high: 1.40102 s/s/y (between 1.03 and
1.80102 s/s/y) (Table 2).
The Bayesian Skyline Plot obtained for HCV-2a showed an
overall constant proﬁle with peaks in the diversity by the time
of samples 6301, 7356 and 9107. The mean Hamming distance of
the HCV-2a clones ranged between 0.56% and 1.65% and showed
some degree of correlation with the skyline proﬁle, since there
were peaks in samples 6524 and 7356. However, for sample 9107,
which showed a peak in the skyline, the Hamming distance was
the lowest (Supplementary Fig. 3B).
Genotype 3a: mixed pattern
The time-annotated tree for HCV-3a clones showed a complex
pattern of evolution (Fig. 5). In the ﬁrst time-point (sample 4188), the
clones formed a cluster that was related to the common ancestor of
the two clusters of the next time-point (sample 5168, after 980 days).
Only one of those clusters was related to the ancestor of all clones of
the following samples. Beyond the third time-point (sample 6301,
another 1133 days), the diversity of the clones increased and then the
clustering of the ancestral sequences was difﬁcult to assign, resulting
in an intermingling of sequences of one time-point with the ancestor
of the further ones. At the amino acid sequence level, all clones of the
ﬁrst time-point showed the same HVR-1 sequence. Similarly, all the
clones for the second time-point showed the same HVR-1, which had
four amino acid differences with that of the previous sample. From
the third time-point onwards, there were different lineages with a
common HVR-1 amino acid sequence but each lineage differing from
each other by one or two amino acid positions. In this case, the
Fig. 3. Time-annotated tree and amino acid alignment of the HVR-1 for HCV-1a E2 Clones. Maximum clade credibility tree of the E2 sequences of HCV-1a cloned. The
number on the right side of each clade is the posterior probability (the rest of the clades had a posterior probability lower than 0.95). Samples: time-point code of the cloned
samples. The sequences are named after their sample time-code and clone number. The X axis represents the time in calendar years. The alignment of HVR-1 is shown on the
right of the sequence names. In the alignment, each letter corresponds to one amino acid following the one-letter IUPAC code. The “-” character represents that this position
is occupied by the amino acid of the same position in the top sequence.
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estimation of the substitution rate for the whole process resulted in
an intermediate substitution rate of 7.26103 s/s/y (between 5.45
and 9.13103 s/s/y) (Table 2).
The Bayesian Skyline Plot obtained for HCV-3a also showed two
periods with different level of diversity: one with low diversity,
which spans from the time of the ﬁrst sample (4188) until the
third one (6301), with a peak in the time of sample 4188; and
another one with high diversity, which spans from sample 6301 to
the last HCV-3a sample (7490), with a groove in the time of
sample 6524.
The mean Hamming distance ranged from 0.64% to 1.83%, and
although the two periods cannot be distinguished by this index,
the mean distance increased with the time (Supplementary
Fig. 3C).
Fig. 4. Time-annotated tree and amino acid alignment of HVR-1 for HCV-2a E2 Clones. Maximum clade credibility tree of the E2 sequences of HCV-2a cloned. The posterior
probabilities (PP) of the supported clades are depicted with stars above the supported node: red stars for PPZ0.99; blue stars for 0.95ZPPo0.99. Samples: time-point code
of the cloned samples. The sequences are named after their sample time-code and clone number. The X axis represents the time in calendar years. The alignment of HVR-1 is
shown on the right of the sequence names. In the alignment, each letter corresponds to one amino acid following the one-letter IUPAC code. The “-” character represents that
this position is occupied by the amino acid of the same position in the top sequence. The Greek letters are the names of the groups of sequences. The sequences from the
same time are shaded with the same color.
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Discussion
The patient analyzed in this work exhibited a co-infection with
three HCV genotypes (1a, 2a and 3a), which is a known issue
among patients with hemophilia treated with human plasma-
derived clotting factors (Lee, 2009). In this case, the analyses of
multiple samples and genotype-speciﬁc primers were required to
unequivocally identify the co-infecting HCV genotypes. This
Fig. 5. Time-annotated tree and amino acid alignment of HVR-1 for HCV-3a E2 Clones. Maximum clade credibility tree of the E2 sequences of HCV-3a cloned. Samples: time-
point code of the cloned samples. The sequences are named after their sample time-code and clone number. The X axis represents the time in calendar years. The alignment
of HVR-1 is shown on the right of the sequence names. In the alignment, each letter corresponds to one amino acid following the one-letter IUPAC code. The “-” character
represents that this position is occupied by the amino acid of the same position in the top sequence. The sequences from the same time are shaded with the same color.
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observation highlights that, to address the actual genotypes
involved in the infection, it is important to carry out a careful
genotype evaluation, especially in the presence of risk factors for a
multiple infection, such as clotting factor treatment.
The evolution of each genotype was followed using direct
sequences as well as cloned sequences by phylogenetic and
coalescence methods. The study of direct sequences showed
differences in the evolutionary patterns exhibited by the E2 region
in each genotype, but no differences in the NS5A region. In
addition, the analyses of cloned sequences conﬁrmed the differ-
ences in the evolutionary dynamics of the E2 region.
Direct sequences
In the phylogenetic analyses, the tree topology for HCV-2a and
3a strongly suggests a relationship between ancestry and sampling
time. Moreover, as a result of exhaustive tree searches, the E2 and
NS5A direct sequence datasets for HCV-2a and 3a yielded comb-
like trees where ancestry was compatible with the sampling time.
That was not the case for the E2 sequences of HCV-1a, in which
“new” samples were located as ancestors of “older” ones.
These observations were further supported by the correlation
between the calendar distance and the branch lengths estimated
in the best trees for HCV-2a and 3a datasets but not for HCV-1a.
This scheme is compatible with the action of either a strict or
relaxed molecular clock, but further analysis was limited by the
low number of taxa in the direct sequence dataset.
In addition, the rough estimations of the substitution rates
estimated for the E2 regions of HCV-2a and -3a were different while
those estimated for the NS5A regions were undistinguishable
(Table 2), suggesting the action of different mechanisms of evolution
in these genomic regions. Although the regression analysis is useful to
explore the temporal structure of the datasets, the assumptions made
for the regression are not fulﬁlled by a phylogeny, making the
estimation of the substitution rate by this means unreliable
(Drummond et al., 2003). These rates (slopes) were further conﬁrmed
by a Bayesian coalescence analysis which may have limitations due to
the low number of sequences in the direct datasets. Despite the
different limitation of these analyses, the results were compatible
with the known characteristics of the E2 and NS5A regions. The HCV
E2 region is characterized as the most variable region as a result of its
interaction with the immune system (von Hahn et al., 2007; Smith
et al., 2010; Guan et al., 2012). In contrast, the NS5A region is a
conserved region thought to be mainly under negative selection due
to its regulatory functions (He et al., 2006). Each infection (in this case
represented by different genotypes), evolving in the same host and at
the same time, showed dissimilar substitution rates at the HCV E2
region, which suggests a different interplay with host's factors. Since
the host's genetic background is constant, the source of this diversity
in the interactions could be the adaptive immune system. In the E2
region of HCV-1a, the amino acid sequence remained constant
throughout the period analyzed, evidencing some degree of immune
tolerance, whereas for HCV-3a, and more clearly for HCV-2a, the
region appears as extremely variable with a higher substitution rate
and broad modiﬁcations at the amino acid sequences.
The results of the direct sequences are in accordance with
previous differences observed for the E2 and NS5A regions and
with the fact that each genotype showed differences in the E2
region as a result of different interplays of each genotype with the
host immune system.
Cloned sequences
For a deeper study of the evolutionary process, a population
genetic analysis was performed using cloned E2 sequences.
The diversiﬁcation process has been associated with several
features of clinical impact (Farci et al., 2006; Bull et al., 2011;
Saludes et al., 2013). The use of coalescence-based methods
allows analyzing the dynamics of viral lineages in the host over
the time (Gray et al., 2012). The analysis of the time-annotated
trees and the Bayesian Skyline Plots allowed the recognition of
complex interactions between the lineages that compose the
whole viral population that circulate in the patient. The popula-
tion genetic analysis showed that, for the three genotypes, new
lineages are generated continuously, but in some case these
lineages can either increase and become dominant or decrease
and ﬁnally become extinct. In the case of HCV-1a, there was a
dominant lineage that prevailed for nearly 3 years, and even when
“new” different sequences were cloned at each time-point, none
of these mutants were ﬁxed in the population (negative selec-
tion). Contrastingly, for HCV-2a, almost every time-point was
characterized (at population level) by co-dominance of two
lineages. Moreover, each lineage showed its own evolutionary
process and some of these even became extinct. HCV-3a showed a
more complex behavior with dominance of one lineage that
allowed the ﬁxation of some variants in the ﬁrst 3 years, but
then switched to the co-dominance of several variants that
prevailed (in different proportion) for the rest of the follow-up.
It is worth noting that these evolutionary patterns have been
previously described in the follow-up of chronic HCV infections in
different hosts (Ramachandran et al., 2011). Interestingly, in this
work, HCV evolution occurred in the same host, which limits the
impact of the particular host background driving the virus
evolution. This highlights the complexity of the host-virus inter-
action, since not only HCV-1a and HCV-2a showed different
manifestations of the evolutionary process in the same host at
the same time, but also HCV-3a showed a change between two
patterns in the period analyzed.
It is possible that the three HCV genotypes in this patient
represent different starting points in an immune escape process
leading to different outcomes. While HCV-1a probably reaches an
equilibrium point where immune evasion was not necessary (most
of the cloned sequences present identical HVR-1 amino acid
sequences), both HCV-2a and HCV-3a were in a continuous
process of selection of new evasion mutants (different sequences
were observed for HVR-1 in the clones).
The recognition of splitting and extinction of lineages can only
be achieved at intra-host viral population level with the aid of
cloned sequences. Novel technologies like pyrosequencing may
also allow modeling the evolutionary dynamics at this level (Wang
et al., 2010) by providing a number of readings (virtual clones) that
may detect even very scarce viral variants, but this information
may not be tractable in the Bayesian-coalescent framework.
Unfortunately, the low HIV viral load and the steady levels of
CD4þ cells observed in the patient throughout the period ana-
lyzed do not provide enough information to make further spec-
ulations about the impact of HIV co-infection (and therapy) over
the evolution of HCV. Likewise, the temporal distance of the direct
(and cloned) HCV sequences to the INF therapy makes it difﬁcult to
link any feature of the HCV evolution to this event.
Finally, these results support a mechanism of evolution for
HCV where new lineages are generated continuously and then, in
some cases, these lineages can either increase and become
dominant or decrease and ﬁnally become extinct. Moreover, the
magnitude of this process may be different for different genotypes
and variable over the time for a same genotype which suggests
that HCV may explore a number of different ways to persist in
the host.
Each genotype evolving in the same patient and at the same
time presents a different evolutionary pattern apparently modu-
lated by the immune pressure of the host.
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This study provides useful information for the management of
co-infected patients and provides insights into the mechanisms
behind the intra-host evolution of HCV.
Materials and methods
Ethical statement
Written informed consent to participate in this study was
obtained from the patient. The study protocol was approved by
the ethics committees of the “Academia Nacional de Medicina”
and “Facultad de Farmacia y Bioquímica de la Universidad de
Buenos Aires” (record number 732575/2010) in accordance with
the 1975 Helsinki Declaration.
Samples
A retrospective study was carried out using plasma samples
from a patient with severe hemophilia A, currently older than 60
years. In his youth, the patient received ﬁrst-generation non-
inactivated clotting factor VIII concentrates which led to the
infection with HIV and HCV. Clinical records (Supplementary
Fig. 1) include CD4 cell counts, HIV and HCV viral loads from
1993 to 2008. Since 1990, he has received uninterrupted antire-
troviral therapy ﬁrst with zidovudine only and then with different
schemes of highly active antiretroviral therapies. In 2003/2004, he
also received anti-HCV treatment (PEG-Interferon plus Ribavirin)
and was considered a partial responder. The samples analyzed in
this study were coded based on their date, counted as days after an
arbitrary date in the past. The numbers coding the dates were
selected so that the resulting dates (including the possible ances-
tor's dates of the different analyses carried out) were higher than
zero in order to avoid possible unhandled exceptions in the
programs due to a “negative time”.
RT-PCR-sequencing
The RNA was extracted from plasma samples using the QIAmp
Viral RNA Mini Kit (QIAGEN) and then transcribed with MMLV
retrotranscriptase (Promega) with random hexamer primers fol-
lowing the manufacturer's recommendations. Then the cDNA was
used as template for the nested polymerase chain reaction (PCR)
protocols with the Go Taq reagents (Promega) and with speciﬁc
primers designed to amplify the 5′UTR (Davidson et al., 1995) and
NS5B (Chen and Weck, 2002) regions used for genotyping. 5′UTR
genotyping was carried out by Restriction Fragment Length Poly-
morphism (RFLP) analysis, as already described (Davidson et al.,
1995). The samples were subtypiﬁed by phylogenetic analysis of
NS5B sequences.
After genotyping, new PCRs were carried out for each sample
using genotype speciﬁc primers for the NS5A and E2 regions
(Supplementary Table 1). These regions represent both structural
and non-structural genomic regions which are thought to be
subject to different kinds of selective pressures.
For the NS5A and E2 regions, a simple PCR protocol was carried
out: 5 ml of the cDNA was used as template for the ﬁrst round PCR
in a ﬁnal volume of 50 ml with 1.5 mM of Mgþ þ , 200 mM of dNTP
(each), 0.4 mM of direct and reverse primers (see Supplementary
Table 1) and 1.25 units of Taq polymerase. The ﬁrst round
comprised initial denaturation at 95 1C for 5 min followed by 30
cycles of denaturation at 95 1C for 1 min, annealing at 55 1C for
1 min and elongation at 72 1C for 1 min. Final elongation at 72 1C
was carried out for 10 min. The same conditions were used for a
second round with 2 ml of ﬁrst round product used as template.
The thermocycler program for the second round was similar to the
ﬁrst one, with the exception of the number of cycles (40 instead of
30) and the annealing temperature (57 1C instead of 55 1C).
All PCR products were puriﬁed using the General Electric
Health Care Illustra GFX PCR and Gel Band DNA extraction kit
and sequenced in an automatic sequencer.
Molecular cloning
The E2 amplicons were cloned into the p-GEM-T Easy Cloning
Vector (Promega) following the manufacturer's protocol, which
provides a blue/white system for clone selection. Brieﬂy, the E2
amplicons were puriﬁed to remove PCR byproducts and primers,
and used as inserts in a ligation reaction with the linearized vector.
After the ligation, the vector was transfected into Escherichia coli
by heat shock, and plated in selective media (LB agar with
Ampicilin, IPTG and X-Gal). White clones were picked and grown
in LB broth overnight. The plasmidic DNA was puriﬁed by in-house
alkaline lysis coupled with Phenol-Chloroform extraction. Then,
the DNA obtained was sequenced using the universal T7 promoter
primer.
Sequence relationship assessment
The phylogenetic relatedness of the E2 sequences cloned was
assessed by phylogenetic reconstruction of the patient's viral
sequences plus the set (non-redundant) of the 10 best hits (lowest
“E value”) retrieved with BLAST for each. To do this automatically,
a BASH script called Blast-Fishing was written (available upon
request). This script performs the BLASTN query retrieving a
desired number of hits (10 in this work). Then, it collects all
BLASTN hit accession numbers, removes the duplicated ones and
downloads the full sequences from GenBank.
The sequences downloaded were then aligned with those
obtained using ClustalX v 2.12 (Larkin et al., 2007), and trimmed
so that they matched the region analyzed. After selecting the best
ﬁt substitution model with ModelTest 3.07 (Posada and Crandall,
1998), the phylogeny was reconstructed by maximum likelihood
using bootstrapping as branch support (1000 pseudoreplica) with
the program PhyML 3.0 (Guindon and Gascuel, 2003) for Linux.
The sequences were considered to be related if they formed a
monophyletic group with a bootstrap value higher than 95.
Phylogenetic analyses
The sequences obtained were visualized and manipulated with
BioEdit v5.7 (Hall, 1999) software and aligned using ClustalX. The
phylogenetic reconstructions were carried out with a maximum
likelihood criterion. The best nucleotide substitution model was
selected for each dataset analyzed according to the Akaike infor-
mation criterion implemented in the program ModelTest. In the
case of small datasets (genotype-speciﬁc NS5A and E2 direct
sequences), the tree search strategy was an exhaustive topology
search performed with the program PAUPn v4.10b (Swofford,
2003)). In the datasets with more than 10 sequences, the tree
search strategy was a heuristic search using the hill climbing
algorithm implemented in the program PhyML v3.0. Regardless of
the tree search strategy, all parameters were adjusted as suggested
by ModelTest. In the case where branch support values were
required, the non-parametric bootstrap analysis was carried out
with PhyML (1000 pseudoreplica).
Molecular clock analyses
Regression of branch lengths versus time
As an initial and intuitive method to measure whether or
not the sequences were correlated with the time of sampling, a
A.C.A. Culasso et al. / Virology 449 (2014) 317–327 325
root-to-tip regression analysis was carried out. Although this
analysis allows the numerical (and chart) representation of the
genetic change as a function of time and is thus useful to explore
the temporal structure of the datasets, the assumptions made for
the regression are not fulﬁlled by a phylogeny, making the
estimation of the substitution rate by this means unreliable
(Drummond et al., 2003). This method is based on the fact that
maximum likelihood tree reconstruction optimizes the length of
the branches so that they represent the amount of genetic change
(m T s; where m represents the substitution rate, T the time and
s an arbitrary scaling factor) that relates sequences, and thus the
linear regression of the “amount of genetic change” (Branch
Length) with the time span between the pairs formed with the
older and each sequence would result in a positive non-zero slope
if the tree topology is comb-like and the sequence has a temporal
structure.
For each dataset, the best tree was transformed into a distance
matrix using the “Pairwise distance matrix” option of the program
HyPhy v2.0 (Kosakovsky Pond et al., 2005) for Windows. Then, the
linear regression was carried out with Prism GraphPad v4.10
(GraphPad Software, San Diego, California, USA, www.graphpad.
com) using the branch length and time distances between each
sample and the oldest one. Thus, all sequences except the oldest
one were considered only one time for the regression.
The software also computes the probability that randomly
selected points result in the same slope as the estimated one (full
description of the test available at http://www.graphpad.com/
guides/prism/6/curve-ﬁtting/index.htm?istheslopesigniﬁcantlydif-
ferentthanzero_.htm).
Bayesian coalescent analysis
The datasets with the cloned sequences were analyzed using
the Bayesian Coalescent framework implemented by BEAST v1.6.1
(Drummond and Rambaut, 2007). After selecting the best ﬁt
substitution model, the datasets were run in BEAST using the
available population (constant, exponential growth, logistic
growth, expansional growth and Bayesian skyline) and clock
models (strict, and relaxed uncorrelated lognormal) for 5107
generations. The results were analyzed using Tracer v1.5 (available
from: http://tree.bio.ed.ac.uk/software/tracer/). The runs were
inspected for convergence, i.e. whether or not the estimated
parameter (clock.rate or meanRate, treemodel.rootHeight), likeli-
hood, prior and posterior yielded an Effective Sample Size (ESS)
greater than 200, and visually to check if there were any trends in
the trace of each parameter. The convergent runs were further
compared with Bayes Factor (Kass and Raftery, 1995) to choose the
population and clock models that best ﬁtted the data. The
substitution rate estimations were taken from these runs and
since the time data were coded in days, the estimators obtained
(in s/s/d) were converted into s/s/y by multiplying by 365.25. The
trees of the selected runs were summarized (annotated) using the
TreeAnnotator utility (BEAST v1.6.1 program) to obtain a repre-
sentation of the coalescent events. The annotated trees were
drawn with the Figtree v1.3.1 program (available from http://
tree.bio.ed.ac.uk/software/Figtree).
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